Final Bids Mark a Turning Point in Estée Lauder’s Portfolio Review
Estée Lauder Companies is edging toward a major portfolio reshuffle as it reportedly receives final bids for Too Faced, Smashbox and Dr. Jart+. The sale process, which began as a rumoured package deal, is now expected to conclude within weeks, underscoring the seriousness of the divestiture. Initial marketing framed the three brands as a single acquisition opportunity, but the strategy evolved: Too Faced and Smashbox are now typically offered together, while Dr. Jart+ is being evaluated separately. Interested bidders range from at least one party exploring all three brands to several focused on the colour cosmetics assets and others targeting Dr. Jart+ alone. Estée Lauder has declined to comment, but the progression to final bids confirms that portfolio restructuring is moving from boardroom discussion to execution, with implications for both the company’s future shape and the broader beauty brand acquisition market.
Why Too Faced, Smashbox and Dr. Jart+ Are on the Block
The Estée Lauder divestiture of Too Faced, Smashbox and Dr. Jart+ reflects a reassessment of what belongs in its long-term portfolio. Too Faced, acquired in 2016, was once a star among younger, trend-driven consumers but has more recently been identified as underperforming. Smashbox, brought in back in 2010, is anchored in professional and colour cosmetics, a segment facing intense competition and margin pressure. Dr. Jart+, in which Estée Lauder first took a minority stake in 2015 before buying out remaining shares in 2019, gave the group a foothold in fast-growing K-beauty and derm-inspired skincare. Yet both Too Faced and Dr. Jart+ were flagged as underperformers in recent annual results. Selling them now allows Estée Lauder to release capital and management attention from brands that no longer fit its sharpened priorities, even though they span distinct, once-strategic niches.
Sharpening Focus on Core Luxury and Prestige Brands
Moving ahead with the Too Faced sale and potential exits from Smashbox and Dr. Jart+ aligns with Estée Lauder’s broader push to streamline operations and concentrate on its most scalable prestige franchises. The company’s portfolio still includes heavyweight names such as Estée Lauder, Clinique, MAC Cosmetics, La Mer, Bobbi Brown, Jo Malone London, Tom Ford, Le Labo and others across skincare, makeup, hair and fragrance. By pruning underperforming or non-core assets, leadership can channel investment into these high-impact brands, which typically command stronger pricing power and global distribution. This portfolio restructuring also supports the ongoing Profit Recovery and Growth Plan, which has already driven cost-cutting, consolidation of service providers and workforce reductions. In an environment where scale, brand equity and operational efficiency are crucial, concentrating on a tighter set of luxury and prestige labels is a logical step toward restoring growth momentum and profitability.
Profit Recovery, Potential Puig Tie-Up and Industry Consolidation
The timing of these potential divestitures is not coincidental. Estée Lauder is in the second year of its Profit Recovery and Growth Plan, introduced to address flagging sales and improve efficiency through cost cuts, outsourcing and process standardisation, including a significant workforce reduction. At the same time, the company has entered exploratory discussions about a possible business combination with Puig, a move that could create a beauty group reportedly valued around USD 40bn (approx. RM184bn), though no terms are confirmed and no agreement is guaranteed. To help fund any potential transaction, Estée Lauder has reportedly engaged J.P. Morgan to structure financing. Against this backdrop, selling non-core assets enhances financial flexibility and simplifies the brand roster. The moves highlight an industry-wide trend: consolidation, portfolio pruning and targeted beauty brand acquisition strategies are becoming central tools for large players navigating slower growth and rising competition.
What the Divestiture Signals for the Future of Beauty Portfolios
If completed, the Estée Lauder divestiture of Too Faced, Smashbox and Dr. Jart+ will send a clear message about how global beauty groups see their future portfolios. First, scale alone is no longer enough; brands must either deliver strong, consistent performance or support a clear strategic role, such as category leadership or entry into high-growth niches. Second, conglomerates are increasingly willing to exit once-hyped assets that no longer meet these criteria, even if they helped define key trends like influencer-led makeup or K-beauty. Third, portfolio restructuring is not just defensive: it creates room for targeted innovation, new partnerships and focused beauty brand acquisition, as companies recycle capital into areas with better long-term potential. For Estée Lauder, narrowing its brand set may ultimately support a more coherent, prestige-led narrative—leaner, but positioned to compete aggressively in an evolving global beauty landscape.